Results from the present study show that in intestinal epithelial cells, EVs from the probiotic strain EcN attenuate the IL-1β-induced alterations affecting serotonin metabolism, oxidative stress, and barrier integrity, thereby pointing to their potential application as a postbiotic in IBD. This evidence concerns the gene IL1B and inflammatory bowel disease.